Picture Berlin Partner Health Capital RegMed Forum 650x124px
Document › Details

AB Sciex (d/b/a Sciex). (3/11/15). "Press Release: Sciex Enables Biopharma Success with Custom Method Development Program". Framingham, MA.

Organisations Organisation AB Sciex (Danaher, Framingham, MA)
  Group Danaher (Group)
  Organisation 2 Sniper Public Relations (Sniper PR)
Products Product Sciex Method Development and Consulting program
  Product 2 mass spectrometry-based analysis of biopharmaceutical
Persons Person Fox, Joseph (Joe) (Danaher 202104– President of Sciex joined 2011 before Bruker + Shimadzu)
  Person 2 Sicurella, Stacey (Danaher 201503 Manager Global PR + Brand for Sciex)

Pharma, BioPharma and CRO Scientists can Partner with SCIEX for Immediate Access to Expert Method Development Services

SCIEX, a global leader in life science analytical technologies, today introduced the SCIEX Custom Method Development and Consulting program for scientists who need help to address the analytical challenges of complex biotherapeutics. This program offers sophisticated guidance, knowledge sharing, and expertise to help customers achieve their analysis goals, from development and production workflows to bioanalytical studies, while allowing scientists to maximize the potential of their SCIEX best-in-class LC/MS and CESI/MS instrumentation. The service includes specialized access to a professional, highly-trained application team, which can develop optimized, custom LC/MS and CESI/MS methods according to a customer’s specific requirements. The SCIEX custom method development and consultation team also offers advanced training to enable researchers to formulate their own methods for analysis in the future.

The SCIEX Method Development and Consulting program enables scientists to address critical challenges faced in analysis of biologics with robust, sensitive method development and consultation. The service can also help dramatically reduce customers’ time to first and accurate result by delivering optimized methods at virtually the same time as the delivery of SCIEX instrumentation.

"Organizations are transitioning to, or expanding, their protein and biotherapeutic analysis programs and this custom method development program is designed to help our partners quickly achieve success in rapidly evolving domains, and in turn grow their businesses,” said Joseph Fox, Senior Director of Pharma Business at SCIEX. “Our goal is to assist a rapidly changing pharmaceutical industry to achieve impactful results quickly, and enhance the quality and speed of bringing new therapeutics to market."

The SCIEX Method Development and Consulting program has initially launched in the Americas only.

Key aspects of the service include:

> An innovative and experienced partner to extend the staffing and expertise level of the customer laboratory

> Shorter time to desired results by combining best-in-class instrumentation with custom, robust method development and training services

> Flexible method development options for high value, low volume workflows, or proof-of-concept experiments

Learn more about SCIEX Custom Method Development and Consulting program.


SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please go to

SCIEX social: Twitter, LinkedIn, and on Facebook.

For research use only. Not for use in diagnostic procedures.

AB Sciex is operating as SCIEX.
© 2015 AB SCIEX. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.

Contact Information

Stacey Sicurella
Manager Global Public Relations and Brand

Editorial follow-up
Patrick Farrell
Sniper Public Relations
on Behalf of SCIEX


Record changed: 2016-06-07


Picture Berlin Partner Voices from Berlin-Brandenburg Formo 650x200px

More documents for Danaher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group ChinaBio Partnering Forum 2022 650x300

» top